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The ability of plasma-generated hydrogen peroxide (H2O2) to traverse bacterial biofilms and the subsequent fate of the 
generated H2O2 has been investigated. An in vitro model, comprising a nanoporous membrane impregnated with artificial 
wound fluid and biofilms of varying maturity was treated with a helium-driven, cold atmospheric pressure plasma jet. The 
concentration of H2O2 generated below the biofilms was quantified.  The results showed that the plasma-generated H2O2 
interacted significantly with the biofilm, thus exhibiting a reduction in concentration across the underlying nanoporous 
membrane. Biofilm maturity exhibited a significant effect on the penetration depth of H2O2, suggesting that well established, 
multilayer biofilms are likely to offer a shielding effect with respect to cells located in the lower layers of the biofilm, thus 
rendering them less susceptible to plasma disinfection. This may prove clinically significant in the plasma treatment of chronic, 
deep tissue infections such as diabetic and venous leg ulcers. Our results are discussed in the context of plasma-biofilm 
interactions, with respect to the fate of the longer lived reactive species generated by cold atmospheric pressure plasma, such 
as H2O2. 
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1. Introduction  
The ability to treat antibiotic resistant microorganisms has 
become paramount in the fight against bacterial infection 
owing to their ever-increasing prevalence. The apparent 
stagnation in antimicrobial drug development has fuelled 
urgent initiatives from a number of prominent healthcare 
organisations tailored towards treating and ultimately 
preventing such infections [1-3]. The extent of the current 
crisis is exemplified according to a predicted annual death toll 
of 10 million by 2050 arising solely from drug resistant 
infections (surpassing that of cancer) [4]. In addition to 
antimicrobial resistance (both de novo and pre-existing), the 
ability of bacteria to form biofilms, (dense, multilayer 
communities of bacterial cells protected by an extracellular 
polymeric substance (EPS)), further encumbers effective 
disinfection owing to changes in the physiological state of the 
cells contained within. Notoriously difficult to treat, it is 
estimated that biofilms are associated with 65% of all bacterial 
infections, rising to 85% when considering chronic infections 
[5]. Biofilms are able to form on a multitude of surfaces; both 
biotic and abiotic, thus providing a significant reservoir of 
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pathogenic microorganisms responsible for numerous human 
infections. Biofilms are reported to be involved in half of all 
hospital-acquired infections, which the World Health 
Organisation estimates to affect 4.5 million people per annum 
in Europe, highlighting the significant challenge currently 
facing the global healthcare community [6, 7].   
Wound infections, specifically chronic wound infections have 
a reported prevalence of 6% in the UK and account for at least 
5.5% of the total NHS expenditure [8]. In the USA such non-
healing wounds carry an annual cost of $25 billion and it has 
been estimated that 1-2% of the population in developed 
countries will develop a chronic wound in their lifetime [9]. 
Wounds (venous, pressure, arterial and diabetic) are the 
leading cause of amputation, the latter being responsible for 
70% of all lower limb amputations which occur globally every 
30 seconds as a direct result of non-healing diabetic ulcers [10, 
11]. The protective nature of the EPS along with the induction 
of various quorum sensing pathways and the subsequent 
alteration in gene expression, has rendered biofilms largely 
recalcitrant to common antimicrobial agents. Hence, the need 
for effective treatment strategies has become imperative in 
reducing both the social and economic burden of wound 
infection [12]. 
Cold atmospheric pressure plasma (CAP) has been proven to 
deliver a potent antimicrobial cocktail of reactive species able 
to successfully decontaminate numerous clinically relevant 
single- and mixed-species biofilms, including those associated 
with significant drug resistance; termed the ‘ESKAPE’ 
pathogens [13-15]. The composition and delivery of reactive 
species generated during CAP therapy, such as reactive 
oxygen and nitrogen species (RONS) may be controlled 
according to the plasma parameters employed, providing an 
attractive therapeutic treatment option currently undergoing 
significant investigation within the scientific community [16, 
17]. Extensive discussion can be found in the literature 
surrounding the effects of the plasma source, the variation in 
operating conditions and the current progress and challenges 
facing CAP therapy in the control of microbial biofilms and 
wound infection [18-22]. The interaction of non-thermal 
plasma with biological material has been well documented in 
terms of bactericidal effects, phenotypic and genetic 
consequences (in both eukaryotic and prokaryotic cells) and 
with respect to plasma-activated liquids [23-25]. Studies have 
been conducted using tissue surrogates such as gelatin and 
agarose, alongside cellular mimics such as phospholipid 
vesicles to track plasma delivery of RONS [26-30]. 
Furthermore, the biofilm penetration depth of CAP-generated 
reactive species has been reported as a function of cell death 
and via computational modelling [31-33]. However, the direct 
quantification of longer-lived species, such as hydrogen 
peroxide (H2O2) has yet to be conducted through living 
biofilms. This study reports the effects of biofilm composition 
on the delivery of plasma-generated H2O2 across the cellular 
interface, thus confirming the ability of biologically active 
plasma-generated products to traverse bacterial biofilms 
according to biofilm density/maturity. The presence of H2O2, 
or lack thereof, may provide insight into the fate of the longer-
lived species generated by CAP and the subsequent 
implications this may have for the safe and effective 
decontamination of chronic wounds.       
2. Materials and Methods  
2.1 Materials  
Tryptic Soy Broth (TSB), Tryptic Soy Agar (TSA), Luria-
Bertani (LB) broth, phosphate buffered saline (PBS) tablets 
(pH 7.4), Brain Heart Infusion (BHI) agar, foetal calf serum 
(FCS) (HyClone), sodium chloride (NaCl), potassium iodide 
(KI), H2O2, peptone, poly (vinyl alcohol) (PVA) (MW 14600–
18600 g mol-1), carboxymethyl cellulose (CMC) and agarose 
were all purchased from Sigma-Aldrich, UK. Biofilms were 
formed on sterile, nanoporous polycarbonate filter membranes 
(Whatman), 19 mm in diameter with an average pore size of 
200 nm.   
2.2 CAP jet  
The plasma jet used consists of a single electrode 
configuration with a 150 mm glass capillary tube and a 15 mm 
external ring copper electrode operating at a distance of 40 
mm from the end of the tube [30]. Helium was used as the 
carrier gas at a fixed flow rate of 0.6 standard litres per minute 
(SLPM). The jet was operated at an applied voltage of 10 kV 
p-p and a frequency of 25 kHz. The distance from the end of 
the capillary tube to the surface of the substrate was 5 mm. 
The jet used predominantly produces H2O2 under the 
described operation parameters [28]. There is evidence that 
the initial interaction of the plasma with ambient air in the gas 
phase is the primary production site for H2O2 [34].  
2.3 Quantification of H2O2 
Potassium iodide (KI) was used to quantify H2O2 
concentration in solution via the generation of a standard 
curve. 1M KI in deionised (DI) water was added to varying 
concentrations of H2O2 at a ratio of 1:1 and incubated at 25 C 
for 30 minutes. Absorbance measurements were taken at 410 
nm using a microplate reader (Spectrostar Omega, BMG 
Labtech) and used to produce a calibration curve 
(Supplementary Information Figure 1) [35]. For quantification 
of plasma-generated H2O2 in PBS, 350 L of PBS was added 
to each well in a 96 well microtiter plate and treated for 0.5 - 
5 minutes. 100 L of the treated solution was then removed, 
added to 1M KI (1:1 v/v) and incubated at 25 C for 30 
minutes. Absorbance measurements were taken as before and 
the concentration calculated using the calibration curve.  
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2.4 Bacterial strains and growth conditions  
Methicillin-resistant Staphylococcus aureus (MRSA) 252 and 
Pseudomonas aeruginosa (P. aeruginosa) PA01 were sourced 
from a bacterial strain collection belonging to the Biophysical 
Research Group housed at the University of Bath, UK. Single 
colonies were cultured from freezer stocks (stored at -80 C) 
on TSA or LB agar for MRSA 252 and PA01, respectively. 
Overnight cultures were grown from single colonies in TSB 
or LB liquid media for MRSA 252 and PA01, respectively. 
Cultures were incubated at 37C with agitation (200 rpm) for 
18 hours to achieve a cell density of 109 colony forming units 
(CFU) / ml.  
2.5 Bacterial biofilm formation 
Overnight cultures of MRSA 252 and PA01 were centrifuged 
at 10,000 x g for 10 minutes, washed and resuspended in fresh 
PBS to an optical density of ~ 0.2 (~ 106 CFU/ml). White 
sterile polycarbonate filter membranes positioned on BHI agar 
were inoculated with 20 L artificial wound fluid (FCS mixed 
in equal volume with 0.85% NaCl and 0.1% peptone) in order 
to better model the wound environment and components 
supporting bacterial growth and adhesion. 30 L of bacterial 
subculture was added to the conditioned membranes. 
Membranes were UV sterilised for 10 minutes prior to 
bacterial inoculation. Plates were incubated at 32C for 8, 12 
and 24 hours [36].  
2.6 Quantification of viable bacterial cells  
Following incubation, biofilms were removed from the plates 
and transferred into 5 mL of PBS. The solutions were vortexed 
at 3000 rpm for 1 minute and sonicated for 15 minutes. This 
process was repeated twice to ensure complete detachment of 
the bacterial cells from the membrane. Serial dilutions were 
carried out in PBS and plated on TSA or LB agar with 
subsequent incubation at 37C for 24 hours to enumerate the 
number of viable bacteria.  
2.7 CAP treatment of bacterial biofilms  
Bacterial biofilms grown for 8, 12 and 24 hours were placed 
atop 350 L of PBS in a 96 well microtiter plate (full 
experimental set-up is shown in Figure 2 Supplementary 
Information). Biofilms were plasma treated for 5 minutes, 
with manual movement of the jet around the circumference of 
the well similarly as in vivo wound treatments. Following 
plasma treatment, 100 L of PBS was removed from each well 
and the concentration of H2O2 determined as before via 
correlation to the standard curve. In order to assess any time-
dependent generation of H2O2 as a result of plasma treatment, 
additional 8 hour biofilms were subject to plasma treatment 
followed by a further 4 hour incubation in situ at 32 C prior 
to H2O2 quantification. Separate experiments were undertaken 
to quantify the number of viable bacterial cells (post plasma 
treatment) as previously described. All experiments were 
conducted in triplicate for each bacterial species and each time 
point.  
2.8 Temperature measurement of plasma jet  
The temperature of the CAP jet and biofilm onto which the jet 
was directed was measured using a Xenics® GOBI-640-GigE 
thermal imaging camera.  Plasma temperature was assessed 
when treating a PA01 biofilm grown for 24 hours and placed 
atop 350 L PBS in 96 well microtiter plate.  
 
2.9 Topical application of H2O2  
The effect of H2O2 on bacterial survival was investigated via 
topical application of H2O2 to 8, 12 and 24 hour biofilms of 
both MRSA 252 and PA01. 100 L of 550 M H2O2 (the same 
concentration of H2O2 produced in solution by the plasma jet 
in 5 minutes) was applied to the surface of the biofilms. The 
concentration of H2O2 below the biofilms was quantified after 
5 minutes, and after 4 hours incubation at 32 C as previously 
described.  
2.10 Hydrogel formulation  
PVA/ CMC hydrogels were prepared by dissolving PVA (5% 
w/v) in DI water and heating to 97 °C with constant stirring to 
facilitate dissolution. The solution was supplemented with 
0.5% w/v CMC, cast to a thickness of 1 mm and stored for 18 
hours at -20 °C to promote cryogenic gelation. Discs of gel 
were cut to a diameter of ~1 cm before being placed atop 350 
L PBS in a 96 well plate and subject to CAP treatment.  
Agarose hydrogels were prepared by dissolving agarose (1.5% 
w/v) in DI water and heating to 90 °C. The solution was 
cooled, supplemented with 0.5 M KI and cast to a thickness of 
1 cm. Biofilms were placed atop discs of gel (~17 mm in 
diameter) before treatment with the CAP jet.  
 
3. Results 
3.1 CAP generation of H2O2 in PBS  
As previously reported, an increase in CAP exposure time 
results in a greater production of H2O2 [28]. The CAP jet used 
and the time dependent generation of H2O2 in PBS is shown in 
Figure 1. The KI calibration curve used to calculate 
concentration is shown in Figure 1 Supplementary 
Information.  
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Figure 1. (A) CAP jet used in this study. (B) Generation of 
H2O2 in PBS as a function of plasma treatment time. Means 
and standard deviations from three independent replicates are 
presented. 
 
3.2 Temperature measurement of plasma jet  
Measurement of the temperature of the plasma jet in contact 
with a P. aeruginosa biofilm reached a maximum temperature 





Figure 2. Temperature of plasma jet (top colour spot) showing 
a temperature gradient within the capillary tube and biofilm 
temperature at point of plasma contact (5 mm gap distance, 
image captured after 5 minutes, scale bar corresponds to 
temperature in ˚C).   
 
3.3 CAP treatment of bacterial biofilms 
The effect of biofilm maturity on the transmission of plasma-
generated H2O2 was first evaluated by calculating bacterial 
cell density of untreated biofilms at various time points, 
corresponding to biofilm incubation time. For comparative 
purposes, biofilms of Gram-positive MRSA 252 and Gram-
negative P. aeruginosa PA01 were chosen as representative 
isolates commonly associated with chronic wound infection 
[37]. Further experiments were conducted evaluating the 
effect of CAP treatment on cell density as a function of biofilm 
maturity as shown in Figure 3. A scanning electron 
micrograph of a 24 hour biofilm is shown in the 
Supplementary Information (Figure 3) in order to highlight the 
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Figure 3. Effect of 5 minutes CAP treatment on cell density 
(CFU/ ml) of P. aeruginosa PA01 (A) and MRSA 252 (B) 
biofilms at varying maturities relative to untreated control 
biofilms. Means and standard deviations from three biological 
replicates are presented. 
Owing to the high bacterial cell densities in the biofilms used 
in this study, it is not unexpected that the application of CAP 
fails to reduce the density of the mature biofilms. Plasma 
treatment of 8 hour biofilms reduces the cell density but does 
not necessarily provide a clinically significant reduction in 
biomass with viable cell count remaining arguably high post 
treatment. Previous studies have focused on the recovery of 
biofilms post CAP treatement as a function of biofilm maturity 
[38]. Additional studies have been reported in which CAP 
therapy is able to significantly reduce or even eliminate 
bacterial biofilms (albeit often when treating biofilms with a 
lower bioburden), however this study concerns the fate of 
CAP-generated RONS as opposed to their biological effect 
[39-40]. Therefore high density biofilms indicative of chronic 
infection were chosen as the cellular interface over which to 
monitor H2O2 formation.  
 
Prior to establishing the concentration of H2O2 able to traverse 
the cellular interface, it was necessary to evaluate transmission 
across the polycarbonate membrane on which the biofilms 
were grown. Plasma treatment through the nanoporous 
membrane for 5 minutes resulted in a 33% reduction in H2O2 
concentration in the PBS below the membrane (relative to 
direct treatment of PBS), as shown in Figure 4. This was taken 
into account in subsequent experiments by the introduction of 
a transmission factor (TF) of 0.67 to account for the 



















Figure 4. Effect of the polycarbonate membrane (a function 
of the experimental protocol) on the generation of H2O2 in 
PBS after 5 minutes, showing a significant reduction in H2O2 
concentration. Means and standard deviations from three 
independent replicates are presented and have been analysed 
using an unpaired t test: ** p = 0.0029.  
 
Considering the TF, the presence of AWF on the membranes 
(included as a pre-treatment prior to bacterial inoculation) was 
also investigated. Membranes were pre-treated with a 
conditioning layer of AWF and incubated at 37 °C for 8, 12 or 
24 hours (in-keeping with subsequent biofilm growth 
conditions) to establish any interference from the conditioning 
layer over time. The concentration of H2O2 generated in the 
PBS below the membrane impregnated with AWF was 
comparable to the membrane only (data shown in Figure 4), 
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Results illustrate no statistical significance with respect to 
H2O2 concentration as a result of the inclusion of AWF or the 
incubation period. This suggests little measurable interference 
of the AWF on the transmission of H2O2 across the interface.  
Table 1. Concentration of H2O2 generated across 
polycarbonate membranes inoculated with AWF following 
incubation for various time periods (taking into account the 
TF). Means and standard deviations from three biological 
replicates are presented and have been analysed using a one-
way ANOVA with multiple comparisons. 
Incubation Time/ hours [H2O2]/ TF / µM 
8 374.9 ± 40.4 
12 520.5 ± 13.1 
24 400.2 ± 96.8 
 
However, Figure 5 shows the presence of bacterial biofilms 
(of all maturities) to have a significant effect on the 
transmission of H2O2 relative to the membrane + AWF only. 
Biofilms grown for 8 hours, corresponding to approximately 
109 CFU/ml, reduced the concentration of H2O2 by 
approximately half, whereas biofilms approaching 1010 
CFU/ml almost entirely prevented the detection of H2O2. The 
results show a significant difference in H2O2 concentration 
when comparing 8 hour biofilms of both MRSA and P. 
aeruginosa to the corresponding 12 and 24 hour biofilms, 
which may be as a direct result of the observed difference in 
bacterial cell death (seen in Figure 3) when comparing 8 hour 
biofilms to more mature biofilms. There is no significant 
difference observed between the 12 and 24 hour biofilms of 
either MRSA or P. aeruginosa; likewise, there is no difference 




















Figure 5. Effect of biofilm composition on the generation of 
H2O2 in PBS below the interface as a function of biofilm 
maturity. Means and standard deviations from three biological 
replicates are presented and have been analysed using a two-
way ANOVA with multiple comparisons: **** p <0.0001. 
 
In order to investigate time-dependent formation and/or 
diffusion of plasma-generated H2O2, PVA/ CMC hydrogels 
were used as a model system prior to commencing biofilm 
analysis. The gels were placed atop wells containing PBS and 
treated with the CAP jet for 5 minutes.  The concentration of 
H2O2 in the PBS was then determined immediately (0 hours 
incubation) and following incubation at 32 °C (skin 
temperature) for 1 - 8 hours (Figure 5) [41]. In this case the 
incubation period facilitated the formation of H2O2 in a time 
dependent manner over the course of 8 hours, reaching a 
maximum concentration within ~ 4 hours.  
 
Figure 6. Effect of incubation time on H2O2 concentration in 
PBS post CAP treatment of PVA/CMC hydrogels. Means and 
standard deviations from three independent replicates are 
presented and have been analysed using a one-way ANOVA 
with multiple comparisons: **** p < 0.0001, *** p < 0.001, 
** p < 0.0001. Statistical significance is reported with respect 
to the concentration of H2O2 detected immediately post 
exposure (0 hours).  
 
However, this trend was not seen when subjecting 8 hour 
biofilms to the same incubation conditions. Conversely, the 
concentration of H2O2 was lower for both MRSA and P. 
aeruginosa post incubation (Figure 7). Previous studies have 
indicated the role of catalase in protecting biofilms from the 
effects of hydrogen peroxide by catalysing its decomposition 
into oxygen and water [42-43]. Both S. aureus and P. 
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aeruginosa are catalase-positive, which could explain the 
results seen in Figure 7 using biofilms that had been incubated 
for 4 hours post CAP treatment. Further experimental studies 
















Figure 7. Effect of incubation time on H2O2 concentration in 
PBS post CAP treatment of 8 hour biofilms. Means and 
standard deviations from three biological replicates are 
presented and have been analysed using a two-way ANOVA 
with multiple comparisons: *** p < 0.001, ** p < 0.0001. 
 
3.4 Visualisation of H2O2 formation  
Qualitative assessment of H2O2 formation (both immediately 
and over time) was undertaken using agarose gels containing 
KI. The hydrogel reservoir was able to indicate the formation 
and diffusion of CAP-generated H2O2 through bacterial 
biofilms via a distinctive colour change upon the liberation of 
iodine. Biofilms were placed on the surface of the gels and 
subjected to CAP treatment. The gels were then imaged 
immediately following exposure, before being incubated for 4 
hours at 32 °C, after which the biofilms were removed and the 
gels imaged once more. In agreement with previous 
quantitative data no colour change was observed within the 
gels during CAP treatment of 24 hour biofilms, whereas an 
immediate colour change was observed with 8 hour biofilms 
of both bacterial species (Supplementary Information Figures 
5 and 6). However, when treating biofilms grown for 12 hours, 
MRSA biofilms facilitated a greater degree of iodine release 
within the agarose gels relative to P. aeruginosa biofilms 
grown for the same length of time. Figure 8 shows the colour 
change within the gels immediately post exposure (A and B) 
and after 4 hours incubation (C and D).  
 
 
Figure 8. 12 hour biofilms of MRSA 252 and P. aeruginosa 
PA01 placed atop agarose gels containing KI and subject to 
CAP treatment imaged immediately post treatment (A, B) and 
after 4 hours incubation at 32C (C, D), compared to the 
uninoculated nanoporous membrane pre-treated with AWF.   
 
This result contrasts with the quantitative data, which 
indicates very little H2O2 generated across the 12 hour 
biofilms of both MRSA and P. aeruginosa into PBS (Figure 
5). Indeed, within the range of the experimental error the 
concentration of H2O2 below the biofilms is effectively equal 
for both species. However, in the case of biofilms placed atop 
a hydrogel surface there is a negligible colour change in the 
gel supporting the P. aeruginosa biofilms, whereas there is a 
clear colour change for the MRSA biofilms (albeit this change 
is small when compared to the ‘membrane only’ control). This 
discrepancy may be due to a number of factors; the delivery 
reservoir (PBS vs a gel matrix) is likely to affect the diffusion 
of reactive species and the uniformity of the biofilms may vary 
(they are matured by time as opposed to thickness and 
therefore there will undoubtedly be some variation). The 
behaviour of the biofilms when placed atop a liquid or solid 
interface may change and/or there may be a change in the 
H2O2 catalysis under these conditions. Such considerations 
when designing experimental protocols for the analysis of 
CAP therapy should be carefully rationalised and investigated 
with respect to the intended application in order to more 
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3.5 Topical application of H2O2  
Owing to the multitude of different processes occurring during 
CAP treatment which go beyond the direct operating 
parameters (to include gas mixing with atmospheric gases and 
mixing at the solution interface) it is challenging to provide a 
representative control for the analysis of plasma-generated 
species across biological interfaces [44]. Consequently, we 
have focused solely on H2O2 transmission (as this is the major 
long-lived species generated by the jet described). H2O2 at the 
same concentration as generated by the CAP jet in 5 minutes 
was topically applied to P. aeruginosa and MRSA biofilms 
determine equivalency between plasma-assisted penetration 
and topical therapy. Whilst it is difficult to compare the results 
directly, topically applied H2O2 was unable to traverse 
biofilms of all maturities indicated by the absence of any 
quantifiable concentration of H2O2 in the PBS reservoir below. 
This was confirmed immediately after the 5 minute exposure 
time and following a subsequent 4 hours incubation at 32 C.  
This result suggests that plasma-generated H2O2 (and possibly 
other CAP-generated RONS), are better able to penetrate 
bacterial biofilms than topical application of the same 
chemical species. Again, this is likely a result of the additional 
processes occurring, including continuous gas flow as a 
driving force into the biofilms, localised heating and/or 
synergistic effects from other plasma-generated RONS.  
 
4. Discussion and Conclusions  
The bioburden of the mature biofilms used in this study is 
arguably much higher than seen in some other studies. 
However, healthy skin is reportedly permanently colonised 
with 103 – 104 microorganisms per cm2 skin (rising to 106 in 
moist areas), as part of a healthy skin microflora [45]. 
Therefore, dense biofilms with high microbial cell counts 
were used to represent the exponential proliferation of 
opportunistic pathogens associated with untreated chronic 
infection. In this study the use of CAP is intended as a 
therapeutic treatment as opposed to a preventative measure 
(whereby treatment may commence at lower cell densities 
than those often considered indicative of progressive 
infection). 
In contrast to other studies, this work describes the effect of 
bacterial biofilms on the fate of plasma-generated products 
rather than any direct cellular effects of CAP therapy on the 
biofilms - an important consideration in the future clinical 
application of cold plasma. This investigation highlights the 
ability of plasma-generated reactive species to traverse live 
biofilms, remaining active despite interaction with the 
bacterial species present. This is observed up to cell densities 
of 109 CFU/ml, above which the concentration of longer lived 
species is significantly reduced when evaluated across the 
interface of the biofilm. Determining the exact mechanism of 
cellular interaction with plasma-generated H2O2 is ongoing. 
Owing to the complexity in determining the exact pathway of 
plasma-generated H2O2 with respect to both the gas phase and 
the liquid interface, there are a number of considerations to 
take into account such as direct interaction of biofilm 
components (including catalase) with plasma-generated H2O2, 
alongside the transport and any subsequent reactions with  
additional plasma-generated RONS [46-47]. Nonetheless, the 
ability of high density bacterial biofilms to influence the 
transmission of such species may have implications for the 
application of CAP therapy in the treatment of chronic 
infection, whereby high bacterial loads may be readily 
encountered. In the context of deep-seated infections, the 
ability to deliver RONS directly into the infected tissues may 
vary with different device designs or may in fact be a 
ubiquitous challenge associated with CAP therapy. This 
should be established with the intention of improving RONS 
delivery and penetration in order to successfully apply this 
technology to highly contaminated wounds. Alongside 
ensuring the efficacy of CAP therapy via adequate penetration 
and delivery of plasma-generated reactive species, the effects 
of such species on other cellular entities cannot be 
underestimated. Ultimately, for the succesful therapeutic 
treatement of infection, a balance must be established between 
efficacious elimination of pathogenic organisms and 
implementaion of adequate controls for the protection of the 
surrounding host tissue.  
 
Further research will focus on establishing the effect of 
catalase on the lifetime and bioavaliability of plasma-
generated H2O2, the effect of CAP-induced bacterial cell death 
on the transmission of H2O2 and any protective effects offered 
by bacterial biofilms with respect to surrounding host tissues. 
Additional research will also aim to investigate the formation 
and transmission of other reactive species such as O2∙-, ∙OH, 
∙HO2, to determine additional transportation mechanisms of 
plasma-generated RONS with respect to the material interface 
(biotic or abiotic).  
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